(NC) When you get sick with an infection, you go to the doctor, who might prescribe an antibiotic. You take the medication as indicated, and in a few days, you start to feel better and are soon back to your old self. But what if it weren’t so simple?
A post-antibiotic era is a very near possibility, and some say that we are actually in the post-antibiotic era already, as there are currently bacteria that are becoming resistant to all medications we have on hand. A recent report by the World Health Organization warns that common infections and minor injuries can kill if we reach the point of a post-antibiotic era. If this happens, common infections that we rely on antibiotics to treat, like pneumonia and urinary tract infections, would become quite dangerous and potentially deadly.
Patients infected with antimicrobial-resistant infections, sometimes referred to as superbugs, may experience increased risk of death and recovery time, leading to a greater emotional and financial burden for families, as well as a greater economic cost to society from increased healthcare and absenteeism from work.
Fortunately, there is something we can do. Healthcare experts are calling for new innovations in science to tackle antimicrobial resistance. We’ll need more investment in research for medical technology to rapidly diagnose infections, technology to monitor and track resistant infections, and the development of new medicines. Healthcare companies like BD – Canada are working to help raise awareness about the risks of antimicrobial-resistant infections and creating the technologies to combat them.
With a bigger, better arsenal of weapons against antimicrobial resistance, we’ll be able to fight superbugs and protect the people most vulnerable to infections.
Find more information at amr.bd.com/en-ca.